These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 4746315)
21. Insulin antibodies and the control of diabetes. Dixon K; Exon PD; Malins JM Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646 [TBL] [Abstract][Full Text] [Related]
22. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin. Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730 [No Abstract] [Full Text] [Related]
23. [Proceedings: 2 years of experiences with monocomponent insulin in diabetic patients]. Fankhauser S; Michl J; Morell B Helv Med Acta; 1974 May; 37(5-6):365-6. PubMed ID: 4605883 [No Abstract] [Full Text] [Related]
24. [Insulin antibody titres--observations on their course in patients with diabetes mellitus. A case report]. Grüneklee D; Takaishi T; Daweke H Munch Med Wochenschr; 1970 Jul; 112(27):1287-91. PubMed ID: 4193069 [No Abstract] [Full Text] [Related]
25. [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin]. Iavicoli M; Di Mario U; Coronel GA; Musacchio N; Arduini P Minerva Endocrinol; 1984; 9(2):115-20. PubMed ID: 6390124 [No Abstract] [Full Text] [Related]
26. [Insulin antibodies in untreated and insulin-treated diabetics]. Ditsov S; Penchev I; Andreev D; Sirakov L; Turkolev N Vutr Boles; 1972; 11(3):95-9. PubMed ID: 4679989 [No Abstract] [Full Text] [Related]
28. Circulating antibodies in diabetics treated with conventional and purified insulins. Klaff LJ; Vinik AI; Berelowitz M; Jackson WP S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712 [TBL] [Abstract][Full Text] [Related]
35. [Glucagon antibodies in the blood of insulin-treated diabetics (effect of monospecific and monocomponent insulin therapy on antibody level)]. Korányi L; Tamás G; Gerö L; Halmos T; Baranyai E; Büki B Orv Hetil; 1981 Jun; 122(23):1371-4. PubMed ID: 7024892 [No Abstract] [Full Text] [Related]
36. [Serum I-125 insulin IgG binding capacity in diabetic patients on a long-term insulin treatment, with reference to indications for monocomponent insulin therapy]. Bruni B; Castellazzi R; Osenda M; Papotti G; Turco GL Minerva Med; 1974 Mar; 65(20):1071-7. PubMed ID: 4827592 [No Abstract] [Full Text] [Related]
37. [Use of labeled insulin for a study of insulin antibodies. II. Study of antibodies in a patient with resistance to insulin]. Foit R; Sieberová R; Kraml J; Prokes J; Zikmund E Vnitr Lek; 1968 Jun; 14(6):530-8. PubMed ID: 5661807 [No Abstract] [Full Text] [Related]
38. A method for determination of anti-insulin antibodies in the plasma of insulin-treated diabetics. Sekso M; Resetić J; Riznar V; Solter M Acta Med Iugosl; 1978; 32(2):125-34. PubMed ID: 665291 [No Abstract] [Full Text] [Related]
39. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy. Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299 [TBL] [Abstract][Full Text] [Related]